This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2019
  • /
  • 10
  • /
  • Herzuma and Truxima biosimilars to be distributed ...
Drug news

Herzuma and Truxima biosimilars to be distributed in Australia by Celltrion and to hospitals by Juno Pharmaceuticals.

Read time: 1 mins
Last updated:19th Oct 2019
Published:19th Oct 2019
Source: Pharmawand

Celltrion Healthcare (Celltrion) has entered into a partnership with Juno Pharmaceuticals (Juno) ( not to be confused with Juno Therapeutics) to market the trastuzumab biosimilar Herzuma and rituximab biosimilar Truxima in Australia. The company also launched Herzuma in Iraq. Under this co-marketing partnership, Celltrion Healthcare Australia the Marketing Authorization holder in Australia for Herzuma and Truxima  will distribute the products in the market. Juno, a leading hospital supplier in Australia, will be responsible for sales promotion and providing hospital contracting services to Australian hospital customers.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.